Evidence map›Paper›PMID 25047842›Full record

ArticleInfection and immunity2014

Mycobacterial gene cuvA is required for optimal nutrient utilization and virulence.

Mushtaq Mir, Sladjana Prisic, Choong-Min Kang, Shichun Lun, Haidan Guo, Jeffrey P Murry, Eric J Rubin, Robert N Husson

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 35 citations in OpenAlex.

  1. Multi-omics analyses of evolvedSynthetic and systems biotechnology · 2026
    Article
  2. Article
  3. Staying in the loop to make ends meet: roles and regulation of GlmR inbioRxiv : the preprint server for biology · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Mutations inmBio · 2023
    Article
  10. Article
  11. The Natural AntimicrobialFoods (Basel, Switzerland) · 2021
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Interaction betweenInfection and drug resistance · 2018
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Mushtaq MirDivision of Infectious Diseases, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Sladjana PrisicDivision of Infectious Diseases, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Choong-Min KangDivision of Infectious Diseases, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Shichun LunCenter for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Haidan GuoCenter for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Jeffrey P MurryDepartment of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, USA.
Eric J RubinDepartment of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, USA.
Robert N HussonDivision of Infectious Diseases, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA robert.husson@childrens.harvard.edu.
Boston Children's Hospital · USHarvard University · USJohns Hopkins Medicine · US

Funding

Chemical Inhibitors to Define an Essential M. Tuberculosis Signaling NetworkR01AI099204 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI HUSSON, ROBERT N · 2012 to 2016
$6.1M
Characterization of M. tuberculosis kinases PknA &PknBR01AI059702 · NIAID · CHILDREN'S HOSPITAL BOSTON · PI HUSSON, ROBERT N · 2004 to 2008
$1.9M
AMINO ACID SUBSTITUTION AT THE NSI-NS2A CLEAVAGE JUNCTION OF DENGUE PROTEINZ01AI000571 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI PETHEL, M · 1990 to 1992
–
NIAID NIH HHS AI0571NIAID NIH HHS AI059702NIAID NIH HHS AI099204NIAID NIH HHS N01 AI030036NIAID NIH HHS N01-AI30036NIAID NIH HHS R01 AI059702NIAID NIH HHS R01 AI099204NICHD NIH HHS P30-HD-1865
6 · The paper itself

Abstract

To persist and cause disease in the host, Mycobacterium tuberculosis must adapt to its environment during infection. Adaptations include changes in nutrient utilization and alterations in growth rate. M. tuberculosis Rv1422 is a conserved gene of unknown function that was found in a genetic screen to interact with the mce4 cholesterol uptake locus. The Rv1422 protein is phosphorylated by the M. tuberculosis Ser/Thr kinases PknA and PknB, which regulate cell growth and cell wall synthesis. Bacillus subtilis strains lacking the Rv1422 homologue yvcK grow poorly on several carbon sources, and yvcK is required for proper localization of peptidoglycan synthesis. Here we show that Mycobacterium smegmatis and M. tuberculosis strains lacking Rv1422 have growth defects in minimal medium containing limiting amounts of several different carbon sources. These strains also have morphological abnormalities, including shortened and bulging cells, suggesting a cell wall defect. In both mycobacterial species, the Rv1422 protein localizes uniquely to the growing cell pole, the site of peptidoglycan synthesis in mycobacteria. An M. tuberculosis ΔRv1422 strain is markedly attenuated for virulence in a mouse infection model, where it elicits decreased inflammation in the lungs and shows impaired bacterial persistence. These findings led us to name this gene cuvA (carbon utilization and virulence protein A) and to suggest a model in which deletion of cuvA leads to changes in nutrient uptake and/or metabolism that affect cell wall structure, morphology, and virulence. Its role in virulence suggests that CuvA may be a useful target for novel inhibitors of M. tuberculosis during infection.

Indexed as

AnimalsBacterial LoadBacterial ProteinsCarbonCulture MediaDisease Models, AnimalGene DeletionInflammationLungMiceMice, Inbred BALB CMycobacterium smegmatisMycobacterium tuberculosisTuberculosisVirulenceVirulence FactorsBacterial ProteinsCarbonCulture MediaVirulence Factors

Identifiers

PMID25047842
PMCPMC4187881
OpenAlexW2111844997

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.